What is not working for the company?
What is working for the company?
|Name||Dec 22||Sep 22|
|Mutual Funds (Change:0.00)||0%||0%|
|Insurance Companies (Change:0.00)||0%||0%|
|Other DIIs (Change:-0.02)||1.66%||1.68%|
|Non Institution (Change:0.73)||48%||47.27%|
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in Fredun Pharmaceuticals Ltd
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
Frequently Asked Questions
What is the Share price of Fredun Pharmaceuticals Ltd (FREDUN)?
Can I buy Fredun Pharmaceuticals Ltd (FREDUN) shares?
How do I buy Fredun Pharmaceuticals Ltd (FREDUN) from Angel One?
- Direct investment: You can buy Fredun Pharmaceuticals Ltd (FREDUN) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Fredun Pharmaceuticals Ltd (FREDUN) shares.
In which sector do Fredun Pharmaceuticals Ltd (FREDUN) belong?
Today's live share price for Fredun Pharmaceuticals Ltd is NSE: N/A, BSE: ₹ 985.00 with a current market capitalization of .
Incorported in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94. It was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietory firm, for the manufacture and export of pharmaceutical formulations. The exports were mainly to Afghanistan and west Africa. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. FPL was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, dry-syrups and ointments. It then set up a formulation unit at Palghar (Thane district), Maharashtra, which commenced commercial production in Aug.'94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind. In Apr.'96, the company came out with a public issue to register its products in the overseas market for exports; to part-finance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of company's turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda & Sri Lanka.Read more